Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease

Int J Mol Sci. 2019 May 6;20(9):2215. doi: 10.3390/ijms20092215.

Abstract

With the progressive epidemics of obesity, non-alcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease in adults and children. The increasing prevalence and incidence of NAFLD with advanced fibrosis is concerning because patients appear to experience higher non-liver-related morbidity and mortality than the general population. Recent clinical evidence suggests that NAFLD is directly associated with an increased risk of cardio-metabolic disorders. This mini review describes briefly the current understanding of the pathogenesis of NAFLD, summarizing the link between NAFLD and cardio-metabolic complications, focusing mainly upon ischemic stroke, type 2 diabetes mellitus (DM), hypertension, chronic kidney disease (CKD) and cardiac arrhythmias. In addition, it describes briefly the current understanding of the pathogenesis of NAFLD.

Keywords: cardiac arrhythmia; cardio-metabolic disorders; chronic kidney disease; diabetes; dyslipidemia; hypertension; ischemic stroke; non-alcoholic fatty liver disease.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / etiology
  • Humans
  • Metabolic Syndrome / epidemiology*
  • Metabolic Syndrome / etiology
  • Non-alcoholic Fatty Liver Disease / complications*
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / etiology